well hopefully they have relayed all required information to the...

well hopefully they have relayed all required information to the CE guys and we can pass go.

i think the fanfare with the launch will be significant and the website should be impressive.

as we have all deduced - think there is around $40m in stock to sell, great cash flow and i think the board have a strong inkling to not raise anymore capital around these levels.

they can match other jurisdiction applications with cash flows from sales from europe.

its held up well considering overall markets but also noticed our other biotech friends such as ACR / UNS have also. not true for our shorted friend MSB, but alas you cannot win them all.

well TIS holders our time is nigh - hopefully we see an upward projection on CE approvals and the commence of sales.